Insider: Cohen Joshua B Co-Chief Executive Officer - Amylyx Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 3,334,683 | 0 | 3,334,683 |
| Value | $49,853,510.85 | $0.00 | $49,853,510.85 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/02/2026 | DDS | 29,282 | Direct | COM | $14.48 | $424,120.49 | 3,334,683 |
| 02/02/2026 | DDS | 15,500 | Direct | COM | $14.68 | $227,592.70 | 3,363,965 |
| 01/16/2026 | DDS | 1,974 | Direct | COM | $13.83 | $27,299.04 | 3,379,465 |
| 01/15/2026 | DDS | 136,193 | Direct | COM | $13.59 | $1,850,794.77 | 3,378,621 |
| 01/06/2026 | DDS | 7,715 | Direct | COM | $11.09 | $85,596.38 | 3,317,632 |
| 09/30/2025 | DDS | 29,733 | Direct | COM | $14.34 | $426,469.34 | 3,325,547 |
| 09/30/2025 | DDS | 200 | Direct | COM | $15.00 | $2,999.50 | 3,325,347 |
| 03/31/2025 | DDS | 21,490 | Direct | COM | $3.47 | $74,482.19 | 3,355,280 |
| 03/03/2025 | DDS | 4,595 | Direct | COM | $3.17 | $14,549.15 | 3,196,652 |
| 02/03/2025 | DDS | 11,851 | Direct | COM | $3.47 | $41,107.56 | 3,201,247 |
| 01/06/2025 | DDS | 7,471 | Direct | COM | $4.05 | $30,232.15 | 3,213,098 |
| 09/30/2024 | DDS | 18,589 | Direct | COM | $3.20 | $59,414.16 | 3,220,569 |
| 03/05/2024 | DDS | 4,135 | Direct | COM | $18.73 | $77,439.87 | 3,023,002 |
| 01/09/2024 | DDS | 5,841 | Direct | COM | $16.33 | $95,372.43 | 2,900,470 |
| 03/16/2023 | DDS | 3,924 | Direct | COM | $32.45 | $127,314.57 | 2,792,617 |
| 03/16/2023 | DDS | 96,076 | Direct | COM | $31.84 | $3,059,021.41 | 2,796,541 |
| 01/06/2023 | AAS | 4,122 | Direct | COM | $36.08 | $148,717.23 | 2,894,463 |
| 01/06/2023 | AAS | 1,846 | Direct | COM | $36.79 | $67,912.12 | 2,892,617 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research